Literature DB >> 22723561

Liver steatosis: concordance of MR imaging and MR spectroscopic data with histologic grade.

Susan M Noworolski1, Maggie M Lam, Raphael B Merriman, Linda Ferrell, Aliya Qayyum.   

Abstract

PURPOSE: To determine if the concordance of magnetic resonance (MR) imaging and MR spectroscopic data with histologic measures of steatosis is affected by histologic magnification level, tissue heterogeneity, or assessment of tissue area versus that of hepatocytes.
MATERIALS AND METHODS: This study was institutional review board approved and HIPAA compliant. Written informed consent was obtained. In- and out-of-phase MR imaging and MR spectroscopic measures of steatosis were compared in 33 patients with nonalcoholic fatty liver disease and in 15 healthy volunteers. Concordance of MR imaging and MR spectroscopic data with histologic findings was assessed for (a) histologic examination at standard (×40 and ×100) versus high magnification (×200 and ×400), (b) heterogeneity and homogeneity of livers, and (c) percentage of tissue and hepatocytes that contained lipids. Evaluations included linear regression and Fisher exact tests.
RESULTS: In- and out-of-phase MR imaging and MR spectroscopic data were well correlated (R2=0.93) and generally concordant with histologic measures. Patients in whom MR fat fractions were higher than expected compared with steatosis grades at standard magnification histologic examination were upgraded significantly more often when high magnification was used than were the remaining patients (100% [10 of 10] vs 47% [7 of 15], P<.01). MR imaging and MR spectroscopic data of homogeneous livers were significantly more likely than those of heterogeneous livers to be concordant with steatosis grades when high magnification was used (81% [13 of 16] vs 47% [8 of 17], P<.05). For all patients, percentage of fat in tissue was lower than that in hepatocytes, which affected individual patients, but not the overall correlation.
CONCLUSION: MR imaging and MR spectroscopic data were generally concordant with histologic measures of steatosis. Discordance between them may reflect differences in magnification at histologic examination and in liver heterogeneity. © RSNA, 2012.

Entities:  

Mesh:

Year:  2012        PMID: 22723561      PMCID: PMC3380413          DOI: 10.1148/radiol.12110673

Source DB:  PubMed          Journal:  Radiology        ISSN: 0033-8419            Impact factor:   11.105


  15 in total

1.  Estimation of hepatic proton-density fat fraction by using MR imaging at 3.0 T.

Authors:  Takeshi Yokoo; Masoud Shiehmorteza; Gavin Hamilton; Tanya Wolfson; Michael E Schroeder; Michael S Middleton; Mark Bydder; Anthony C Gamst; Yuko Kono; Alexander Kuo; Heather M Patton; Santiago Horgan; Joel E Lavine; Jeffrey B Schwimmer; Claude B Sirlin
Journal:  Radiology       Date:  2011-01-06       Impact factor: 11.105

2.  Prevalence and risk factors of focal sparing in hepatic steatosis.

Authors:  W Kratzer; A S Akinli; M Bommer; F Arnold; S Eggink; A Imhof; R A Mason; J Klaus; A Schuler; B O Boehm; M M Haenle
Journal:  Ultraschall Med       Date:  2010-02-15       Impact factor: 6.548

Review 3.  Nonalcoholic steatohepatitis: summary of an AASLD Single Topic Conference.

Authors:  Brent A Neuschwander-Tetri; Stephen H Caldwell
Journal:  Hepatology       Date:  2003-05       Impact factor: 17.425

4.  Quantification of hepatic steatosis with T1-independent, T2-corrected MR imaging with spectral modeling of fat: blinded comparison with MR spectroscopy.

Authors:  Sina Meisamy; Catherine D G Hines; Gavin Hamilton; Claude B Sirlin; Charles A McKenzie; Huanzhou Yu; Jean H Brittain; Scott B Reeder
Journal:  Radiology       Date:  2011-01-19       Impact factor: 11.105

5.  Respiratory motion-corrected proton magnetic resonance spectroscopy of the liver.

Authors:  Susan M Noworolski; Phyllis C Tien; Raphael Merriman; Daniel B Vigneron; Aliya Qayyum
Journal:  Magn Reson Imaging       Date:  2008-11-06       Impact factor: 2.546

6.  Magnetic resonance imaging and spectroscopy for monitoring liver steatosis.

Authors:  Gary J Cowin; Julie R Jonsson; Judith D Bauer; Susan Ash; Azmat Ali; Emma J Osland; David M Purdie; Andrew D Clouston; Elizabeth E Powell; Graham J Galloway
Journal:  J Magn Reson Imaging       Date:  2008-10       Impact factor: 4.813

7.  Fatty infiltration of the liver. Quantification by 1H localized magnetic resonance spectroscopy and comparison with computed tomography.

Authors:  R Longo; C Ricci; F Masutti; R Vidimari; L S Crocé; L Bercich; C Tiribelli; L Dalla Palma
Journal:  Invest Radiol       Date:  1993-04       Impact factor: 6.016

8.  Liver steatosis quantification using magnetic resonance imaging: a prospective comparative study with liver biopsy.

Authors:  Nicolas Mennesson; Jérôme Dumortier; Valérie Hervieu; Laurent Milot; Olivier Guillaud; Jean-Yves Scoazec; Frank Pilleul
Journal:  J Comput Assist Tomogr       Date:  2009 Sep-Oct       Impact factor: 1.826

9.  Quantification of hepatic steatosis with MRI: the effects of accurate fat spectral modeling.

Authors:  Scott B Reeder; Philip M Robson; Huanzhou Yu; Ann Shimakawa; Catherine D G Hines; Charles A McKenzie; Jean H Brittain
Journal:  J Magn Reson Imaging       Date:  2009-06       Impact factor: 4.813

10.  Assessment of hepatic steatosis: comparison of quantitative and semiquantitative methods in 108 liver biopsies.

Authors:  Bruno Turlin; Grant A Ramm; David M Purdie; Fabrice Lainé; Michelle Perrin; Yves Deugnier; Graeme A Macdonald
Journal:  Liver Int       Date:  2008-10-19       Impact factor: 5.828

View more
  11 in total

1.  Human immunodeficiency virus-infected and uninfected adults with non-genotype 3 hepatitis C virus have less hepatic steatosis than adults with neither infection.

Authors:  Jennifer C Price; Yifei Ma; Rebecca Scherzer; Natalie Korn; Kyle Tillinghast; Marion G Peters; Susan M Noworolski; Phyllis C Tien
Journal:  Hepatology       Date:  2017-02-03       Impact factor: 17.425

2.  In vivo and ex vivo measurements: noninvasive assessment of alcoholic fatty liver using 1H-MR spectroscopy.

Authors:  Daniel Keese; Hüdayi Korkusuz; Frank Huebner; Dmitry Namgaladze; Bahram Raschidi; Thomas J Vogl
Journal:  Diagn Interv Radiol       Date:  2016 Jan-Feb       Impact factor: 2.630

Review 3.  Non-invasive methods for the diagnosis of nonalcoholic fatty liver disease.

Authors:  Marianthi Papagianni; Areti Sofogianni; Konstantinos Tziomalos
Journal:  World J Hepatol       Date:  2015-04-08

4.  Controlled attenuation parameter and magnetic resonance spectroscopy-measured liver steatosis are discordant in obese HIV-infected adults.

Authors:  Jennifer C Price; Jennifer L Dodge; Yifei Ma; Rebecca Scherzer; Natalie Korn; Kyle Tillinghast; Marion G Peters; Susan Noworolski; Phyllis C Tien
Journal:  AIDS       Date:  2017-09-24       Impact factor: 4.177

5.  Quantitative magnetic resonance imaging of hepatic steatosis: Validation in ex vivo human livers.

Authors:  Peter Bannas; Harald Kramer; Diego Hernando; Rashmi Agni; Ashley M Cunningham; Rakesh Mandal; Utaroh Motosugi; Samir D Sharma; Alejandro Munoz del Rio; Luis Fernandez; Scott B Reeder
Journal:  Hepatology       Date:  2015-09-28       Impact factor: 17.425

6.  Effects of n-3 fish oil on metabolic and histological parameters in NASH: a double-blind, randomized, placebo-controlled trial.

Authors:  Curtis K Argo; James T Patrie; Carolin Lackner; Thomas D Henry; Eduard E de Lange; Arthur L Weltman; Neeral L Shah; Abdullah M Al-Osaimi; Patcharin Pramoonjago; Saumya Jayakumar; Lukas P Binder; Winsor D Simmons-Egolf; Sandra G Burks; Yongde Bao; Ann Gill Taylor; Jessica Rodriguez; Stephen H Caldwell
Journal:  J Hepatol       Date:  2014-09-06       Impact factor: 25.083

7.  The impact of metabolic syndrome and prevalent liver disease on living donor liver transplantation: a pressing need to expand the pool.

Authors:  Waleed Al-Hamoudi; Faisal Abaalkhail; Abdurahman Bendahmash; Naglaa Allam; Bassem Hegab; Yasser Elsheikh; Hamad Al-bahili; Nasser Almasri; Mohammed Al-sofayan; Saleh Alabbad; Mohammed Al-Sebayel; Dieter Broering; Hussien Elsiesy
Journal:  Hepatol Int       Date:  2015-09-04       Impact factor: 6.047

8.  Effects of Dietary Fructose Restriction on Liver Fat, De Novo Lipogenesis, and Insulin Kinetics in Children With Obesity.

Authors:  Jean-Marc Schwarz; Susan M Noworolski; Ayca Erkin-Cakmak; Natalie J Korn; Michael J Wen; Viva W Tai; Grace M Jones; Sergiu P Palii; Moises Velasco-Alin; Karen Pan; Bruce W Patterson; Alejandro Gugliucci; Robert H Lustig; Kathleen Mulligan
Journal:  Gastroenterology       Date:  2017-06-01       Impact factor: 22.682

9.  Analysis of liver steatosis analysis and controlled attenuation parameter for grading liver steatosis in patients with chronic hepatitis B.

Authors:  Xinping Ren; Shujun Xia; Lu Zhang; Ruokun Li; Wei Zhou; Ri Ji; Jianqiao Zhou; Jingyan Tian; Weiwei Zhan
Journal:  Quant Imaging Med Surg       Date:  2021-02

10.  Is MR spectroscopy really the best MR-based method for the evaluation of fatty liver in diabetic patients in clinical practice?

Authors:  Daniella Braz Parente; Rosana Souza Rodrigues; Fernando Fernandes Paiva; Jaime Araújo Oliveira Neto; Lilian Machado-Silva; Valeria Lanzoni; Carlos Frederico Ferreira Campos; Antonio Luis Eiras-Araujo; Pedro Emmanuel Alvarenga Americano do Brasil; Philippe Garteiser; Marilia de Brito Gomes; Renata de Mello Perez
Journal:  PLoS One       Date:  2014-11-26       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.